Chelsea Therapeutics, Inc. Completes Public Offering Of Common Stock

CHARLOTTE, N.C., Nov. 18, 2013 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP), a development stage pharmaceutical company focused on the acquisition, development and commercialization of innovative pharmaceutical products, announced today that it has completed its previously announced public offering of 7,666,667 shares of its common stock, including 1,000,000 shares of common stock that were issued upon exercise in full of the over-allotment option granted to the underwriters. Exercise of the full over-allotment option increases the net proceeds to the Company, after underwriting discounts and commissions and expenses, from approximately $18.6 million to approximately $21.4 million.

Help employers find you! Check out all the jobs and post your resume.